The global bone densitometers market size was estimated at USD 893.7 million in 2016 and is expected to grow at a CAGR of 3.9% over the coming years. The market is predominantly driven by a notable increase in the prevalence of osteoporosis globally. This unprecedented rise has resulted in high demand for bone densitometers for efficient assessment, thereby broadening the growth potential over the coming years. Moreover, the growing geriatric population that possesses high susceptibility toward developing osteoporosis is further anticipated to impel the overall demand for these tools.
U.S. bone densitometers market, by technology, 2014 - 2025 (USD Million)
An upsurge in the prevalence of osteoporosis in menopausal women is predicted to be a key growth contributing factors of the market. According to the statistics published by the International Osteoporosis Foundation, approximately 200 million women are affected by osteoporosis globally. It was also stated that 1/10th of these women belonging to the age group of 60 years, 2/5th to 80 years, 1/5th to 70 years, and 2/3th to 90 years experienced osteoporosis. In addition, about 1 in 3 women over the age of 50 were found to suffer from osteoporotic fractures.
According to the National Institutes of Health Osteoporosis and Related Bone Diseases, certain lifestyle-associated habits that include sedentary lifestyle, alcohol abuse, and smoking are major causes that promote this condition in the male population. The aforementioned factors pose a clinical urgency to curb the growing prevalence of osteoporosis, thus fueling the adoption rate of bone densitometers for early diagnosis.
Furthermore, consistent technological advancements over the years such as the advent of integrated digital detectors and computer-assisted & ultrasound densitometers exhibit high ease of operation as well as reduced measurement time. The ultrasound bone densitometers have enabled assessment in diverse medical specialties, such as gynecology, endocrinology, and others.
The growing demand is also believed to be a consequence of collaborative research initiatives and new product developments undertaken by the prominent market players consistently striving to enhance osteoporosis diagnostics. Also, research funding opportunities by healthcare organizations to develop advanced products is further expected to impel growth. For instance, GE Healthcare developed Lunar Expert, a densitometer equipped with spatial resolution, which enabled improved identification and risk assessment by clinicians through advanced visualization and also reduced image blurring.
Axial bone densitometry accounted for the largest share of over 60% in the product segment in 2016 owing to the high adoption of densitometers based on this technology. The increasing adoption rate can be attributed to the fulfillment of different requirements of clinicians by axial bone densitometers. These predominantly include central dual energy x-ray absorptiometry-based tools that are imperative to obtain accurate results in diagnostic procedures.
In addition, bone densitometers are also presumed to be highly cost-efficient, possessing optimum linearity, sensitivity, and precision, which thereby ensure minimum performance variation. The aforementioned benefits are predicted to be highly responsible for encouraging clinicians to use them.
Global bone densitometers market share, by region, 2016 (%)
Hospitals held a substantial share of the end-user segment in 2016, which can be attributed to the frequent readmissions and high patient volume. In addition, the presence of sophisticated infrastructure facilitates high efficiency in diagnostic procedures involving bone densitometers, thereby adding to a higher share of hospitals.
The increasing inclination of government healthcare organizations to promote advanced diagnostic instruments that generate rapid results also serves as one of the key factors responsible for the substantial share of the segment. Furthermore, in the present scenario, hospitals increasingly use fully automated systems possessing the ability to assess this condition at early stages. These factors cumulatively are also expected to exert a positive influence on the segment growth in the coming years.
In 2016, North America accounted for the largest share of the bone densitometers market. Various collaborative efforts undertaken by prominent companies in this region to improve their R&D capabilities and maintain high medical standards are expected to propel the demand across this region. The majority share captured by this region is also due to the high disease (osteoporosis) burden in this region.
Asia Pacific market is anticipated to grow at an exponential CAGR during the forecast period. This growth is predicted to be a consequence of high demand to curb the increasing prevalence, increasing disposable income, and infrastructural improvements in healthcare facilities. Growing awareness pertaining to osteoporosis care in the emerging economies, such as India and China, is also going to present the bone densitometers industry with potential growth opportunities in the future.
This industry is expected to exhibit extensive competition during the forecast period owing to the rising number of collaborative strategies between the key companies in order to obtain a competitive advantage over others. The other strategies incorporated are mergers & acquisitions, high R&D investment, and agreements for new product development.
For instance, in August 2014, Hologic, Inc. received regulatory approval in Canada for horizon DXA platform with enhanced technical capabilities and workflow efficiencies. This product was launched for enhanced bone mapping, image quality, and precision & stability, which was achieved through integrated high-resolution multielement and ceramic detector array.
Report Attribute |
Details |
Market size value in 2020 |
USD 1035.7 million |
Revenue forecast in 2025 |
USD 1.2 billion |
Growth Rate |
CAGR of 3.9% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, end use, region |
Regional scope |
North America; Europe; APAC; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa |
Key companies profiled |
BeamMed Ltd; CompuMed, Inc.; Hologic, Inc.; GE Healthcare; DMS Group; Osteometer MediTech, Inc.; Lone Oak Medical Technologies LLC |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global bone densitometers market on the basis of technology, end use, and region:
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Axial Bone Densitometry
Dual Energy X-Ray Absorptiometry (DEXA)
Quantitative Computed Tomography (QCT)
Peripheral Bone Densitometry
Single Energy X-Ray Absorptiometry (SEXA)
Dual Energy X-Ray Absorptiometry (pDEXA)
Radiographic Absorptiometry (RA)
Quantitative Ultrasound (QUS)
Peripheral Quantitative Computed Tomography (pQCT)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Clinics
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
b. The global bone densitometers market size was estimated at USD 997.4 million in 2019 and is expected to reach USD 1035.7 million in 2020.
b. The global bone densitometers market is expected to grow at a compound annual growth rate of 3.9% from 2019 to 2025 to reach USD 1261.7 million by 2025.
b. North America dominated the bone densitometers market with a share of 34.43% in 2019. This is attributable to various collaborative efforts undertaken by prominent companies in this region to improve their R&D capabilities and maintain high medical standards.
b. Some key players operating in the bone densitometers market include BeamMed Ltd, CompuMed, Inc., Hologic, Inc., GE Healthcare, DMS Group, Osteometer MediTech, Inc., Lone Oak Medical Technologies LLC.
b. Key factors that are driving the bone densitometers market growth include increasing prevalence of osteoporosis, growing geriatric population, consistent technological advancements and collaborative research initiatives and new product developments undertaken by the prominent market players.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.